AKR1C2
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Ebert, Kisiela, Wsól, Maser: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
Target
AKR1C2
(Aldo-keto Reductase Family 1, Member C2 (AKR1C2))
AKR1C-pseudo antikoerper, BABP antikoerper, DD antikoerper, DD2 antikoerper, DDH2 antikoerper, HAKRD antikoerper, HBAB antikoerper, MCDR2 antikoerper, SRXY8 antikoerper, Akr1c21 antikoerper, aldo-keto reductase family 1 member C2 antikoerper, aldo-keto reductase family 1, member C2 antikoerper, AKR1C2 antikoerper, Akr1c2 antikoerper
Hintergrund
Full Gene Name: aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2, bile acid binding protein, 3-alpha hydroxysteroid dehydrogenase, type III) Synonyms: AKR1C-pseudo,BABP,DD,DD2,DDH2,HAKRD,HBAB,MCDR2